Street Talk

New York VC takes stake in Aussie start-up promising longevity

Sarah Thompson, Kanika Sood and Emma Rapaport

Jul 22, 2025 – 5.00am

Subscribe to gift this article

Gift 5 articles to anyone you choose each month when you subscribe.

Already a subscriber?

Everlab, a preventive healthcare startup that performs full-body MRI scans to screen for potential problems in asymptomatic patients, is ready for international expansion after closing off one of Australia’s largest seed rounds for 2025.

The Melbourne-based start-up has secured $15 million in seed funding in a round led by Left Lane Capital, a New York and London-based venture capital and growth equity firm. The funds will fuel Everlab’s international expansion efforts into Europe, the United States and across the Asia-Pacific in 2026, and grow its clinic network and develop the platform.

Sarah Thompson has co-edited Street Talk since 2009, specialising in private equity, investment banking, M&A and equity capital markets stories. Prior to that, she spent 10 years in London as a markets and M&A reporter at Bloomberg and Dow Jones.

Kanika Sood is a journalist based in Sydney who writes for the Street Talk column.

Emma Rapaport is a co-editor of the Street Talk column. Prior to that, she was a markets reporter at The Australian Financial Review.